📗 Cite This Artifact
Latin American Neurodegeneration Research and Biotech
Overview
Overview
Latin America has a growing research infrastructure for neurodegenerative disease research, with key centers in Brazil, Argentina, Mexico, and Chile conducting important studies on Alzheimer's disease, Parkinson's disease, and related disorders. This page covers the regional research landscape, notable institutions, and emerging biotech opportunities.
Key Research Institutions
Brazil
São Paulo Research Foundation (FAPESP)
- Location: São Paulo, Brazil
- Focus: Funding agency supporting neurodegeneration research
- Notable: One of Latin America's largest research funders
- Website: fapesp.br
Butantan Institute
- Location: São Paulo, Brazil
- Focus: Biomedical research, including neuroscience
- Notable: Major vaccine and therapeutics research
Federal University of São Paulo (UNIFESP)
- Location: São Paulo, Brazil
- Focus: Neurology and neuroscience research
- Notable: Leading PD research programs in Latin America
René Rachou Institute (Fiocruz)
- Location: Belo Horizonte, Brazil
- Focus: Tropical diseases, emerging neuroscience research
Argentina
Instituto de Neurociencias de Buenos Aires (INBA)
- Location: Buenos Aires, Argentina
- Focus: Basic and translational neuroscience
- Notable: Strong PD research program
Universidad de Buenos Aires (UBA)
- Location: Buenos Aires, Argentina
- Focus: Neurology and psychiatry research
- Notable: Largest university research system
Mexico
Instituto Nacional de Neurología y Neurocirurgia (INNN)
- Location: Mexico City, Mexico
- Focus: Neurological disorders, including AD and PD
- Notable: National reference center
Universidad Nacional Autónoma de México (UNAM)
- Location: Mexico City, Mexico
- Focus: Neuroscience research
- Notable: Largest university in Latin America
Chile
Universidad de Chile
- Location: Santiago, Chile
- Focus: Aging and neurodegeneration research
- Notable: Strong basic science program
Regional Collaborations
Latin American Study Group on Aging (GEPEN)
- Focus: Geriatrics and neurodegeneration
- Members: Researchers from Brazil, Argentina, Mexico, Chile
- Activities: Clinical trials, research networks
Brazilian Aging Studies
- Population: Large elderly population for clinical studies
- Opportunity: Genetic diversity in research
- Challenge: Infrastructure development needed
Clinical Research
Active Clinical Trials
Latin America hosts numerous clinical trials for neurodegenerative diseases:
| Phase | AD Trials | PD Trials | Location |
|-------|-----------|-----------|----------|
| I | 3 | 5 | Brazil |
| II | 5 | 8 | Brazil, Argentina |
| III | 10 | 15 | Multiple |
Research Opportunities
- Genetic diversity: Unique population genetics
- Large patient pools: Aging populations
- Cost efficiency: Lower trial costs than US/EU
Challenges and Future Directions
Infrastructure Needs
Emerging Opportunities
- Biotech startups: Growing ecosystem in Brazil and Mexico
- Academic spin-outs: Technology transfer from universities
- International partnerships: Collaborations with US/EU centers
Research Focus Areas
Alzheimer's Disease Research
Latin American researchers contribute to AD research in several key areas[@neurodegeneration2023]:
- Epidemiology: Population-based studies on prevalence and risk factors
- Genetics: Investigation of unique genetic variants in Latin American populations
- Biomarkers: Development of culturally appropriate cognitive assessments
- Clinical trials: Participation in international Phase II/III trials
Parkinson's Disease Research
The region has strong PD research programs[@parkinsons2023]:
- Movement disorders: Specialized centers in São Paulo, Buenos Aires, Mexico City
- Genetics: Studies on [LRRK2](/entities/lrrk2) and [GBA](/entities/gba) variants in Latin American populations
- Clinical outcomes: Long-term follow-up studies
- Cell therapy: Early research on stem cell approaches
Tauopathies and Related Disorders
- PSP and CBD: Clinical characterization studies
- Dementia with Lewy Bodies: Growing research interest
- FTD: Emerging programs in major centers
Technology Transfer and Innovation
University Spin-outs
Several Latin American universities are developing technology transfer offices to commercialize research:
- USP Innovation Agency: Technology transfer office at University of São Paulo
- UNAM Innovation: Technology transfer at Universidad Nacional Autónoma de México
- CONICET: Argentine research council technology transfer programs
Incubators and Accelerators
- Innova BR: Brazilian biotech incubator
- M指定BIO: Mexican life sciences accelerator
- Start-up Chile: Innovation support program
Funding Landscape
Government Funding
| Country | Funding Agency | Focus |
|---------|---------------|-------|
| Brazil | FAPESP, CNPq | Basic and clinical research |
| Argentina | CONICET | Basic science |
| Mexico | CONACYT | Applied research |
| Chile | ANID | Innovation |
International Collaboration
- Fogarty International: NIH funding for Latin American neuroscience
- European Union: Horizon America research partnerships
- World Health Organization: Regional neurology initiatives
Training and Education
Graduate Programs
- Master's programs: Neuroscience and neurology in major universities
- PhD programs: Collaborative programs with international institutions
- Clinical fellowships: Movement disorders specialization
International Training
- Fellowships abroad: Latin American neurologists train at US/EU centers
- Exchange programs: Student and researcher mobility
- Conference attendance: Regional meetings and international conferences
Conclusion
Latin America represents an emerging hub for neurodegeneration research with significant potential. The region's large and aging population, growing research infrastructure, and unique genetic diversity position it for important contributions to understanding and treating neurodegenerative diseases. Continued investment in infrastructure and training will be essential for the region to reach its full potential.
[@neurodegeneration2023]: [Alzheimer's disease research in Latin America](https://doi.org/10.1016/j.jns.2023.01.015)
[@parkinsons2023]: [Parkinson's disease in Latin American populations](https://doi.org/10.1016/j.parkreldis.2023.01.001)
See Also
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
External Links
- [PubMed](https://pubmed.ncbi.nlm.nih.gov/)
- [KEGG Pathways](https://www.genome.jp/kegg/pathway.html)
References
▸Metadataorigin_type: v1_polymorphic_backfill
| slug | companies-latin-american-neurodegeneration-research |
| kg_node_id | None |
| entity_type | company |
| origin_type | v1_polymorphic_backfill |
| source_table | wiki_pages |
| wiki_page_id | wp-13299e1207e5 |
| __merged_from | {'merged_at': '2026-05-13', 'unprefixed_id': 'companies-latin-american-neurodegeneration-research'} |
| _schema_version | 1 |
No provenance edges found
Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.
<iframe src="http://scidex.ai/artifact/wiki-companies-latin-american-neurodegeneration-research?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>
[Latin American Neurodegeneration Research and Biotech](http://scidex.ai/artifact/wiki-companies-latin-american-neurodegeneration-research)
http://scidex.ai/artifact/wiki-companies-latin-american-neurodegeneration-research